AFFECT Study for Patients With Intraventricular Hemorrhage, Subarachnoid Hemorrhage, Subdural Hematoma, and Ventriculitis

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 240 participants.

Also called NCT05649904

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 240 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05649904
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05649904. Randomized; no masking; primary purpose treatment. Start 2023-02-07 (actual); primary completion 2026-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
AFFECT Study for Patients With Intraventricular Hemorrhage, Subarachnoid Hemorrhage, Subdural Hematoma, and Ventriculitis
Acronym
AFFECT
Condition
Intraventricular Hemorrhage
Condition
Subarachnoid Hemorrhage
Condition
Subdural Hematoma
Condition
Ventriculitis
Intervention (Device)
IRRAflow with Active Fluid Exchange System
Intervention (Device)
External Ventricular Drain
Lead sponsor
Ohio State University (class: other)
Collaborator
IRRAS (class: industry)

Record details

Record id
cardio:ct-nct05649904
Content hash
35a7bca688e8b97e3d0c36271e643095b62c2a4a70e26168d0ad5a336e8d6fbc